Merck & Co. Inc., AbbVie Inc., Bristol-Myers Squibb Co. and Bayer AG were among the healthcare companies who adjusted either revenue or earnings forecasts for 2018 after the first quarter to reflect anticipated performance growth or decline.
Guidance for some of the largest pharmaceutical and biotechnology companies by market value are listed below.

